
Biotechnology • Pharmaceuticals • Healthcare Insurance
Immunovant is a company focused on advancing treatments for autoimmune diseases through a patient-focused approach. With a vision of enabling normal lives for people with autoimmune diseases, Immunovant applies its expertise in science to develop and test new therapies. The company emphasizes complex and variable needs across different stages and severities of diseases. Immunovant is committed to pushing forward its therapeutic areas and clinical trials, while also engaging with patients, caregivers, and investors about their ongoing studies and corporate initiatives.
November 25
Director of Clinical Operations managing clinical oversight at Immunovant, Inc. leading strategies and collaborations across cross-functional teams for autoimmune research.
November 19
Director of Clinical Pharmacology at IMVT Corporation responsible for strategic development of clinical programs. Collaborating with internal and external stakeholders in a biotech startup environment.
November 19
Senior Director of Clinical Pharmacology in clinical-stage immunology company, leading clinical pharmacology plans and execution across therapeutic areas and phases.
October 27
Senior Manager in Statistical Programming for Immunovant, analyzing clinical trial results and statistical input for reporting. Interacting with CROs and maintaining SAS libraries for effective data management.
October 15
Director, GCP Auditing Lead ensuring compliance with regulatory standards for Immunovant’s clinical studies. Planning and executing GCP audit programs with risk-based approaches.
September 17
Associate Director overseeing late-stage biologic drug product commercialization for Immunovant. Drive process scale-up, tech transfer, PPQ, regulatory filings, and CDMO management.